Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-15ARQT144Sue-Jean Lin plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Sue-Jean Lin filed Form 144 to notify SEC of plan to sell 4946 units of Arcutis Biotherapeutics, Inc. securities around 2026-06-15, with aggregate market value of $120,586.79. The total outstanding units is 125083374.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mid CapBiotechnology